Alexandru Eniu

Alexandru Eniu

UNVERIFIED PROFILE

Are you Alexandru Eniu?   Register this Author

Register author
Alexandru Eniu

Alexandru Eniu

Publications by authors named "Alexandru Eniu"

Are you Alexandru Eniu?   Register this Author

45Publications

1828Reads

38Profile Views

Mapping cancer research across Central and Eastern Europe, the Russian Federation and Central Asia: Implications for future national cancer control planning.

Eur J Cancer 2018 11 20;104:127-136. Epub 2018 Oct 20.

Institute of Cancer Policy, Cancer Epidemiology, Population & Global Health, School of Cancer Sciences, King's College London & Guy's & St.Thomas' NHS Trust, London, UK. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ejca.2018.08.024DOI Listing
November 2018

Aberrant miRNAs expressed in HER-2 negative breast cancers patient.

J Exp Clin Cancer Res 2018 Oct 20;37(1):257. Epub 2018 Oct 20.

Research Center for Functional Genomics, Biomedicine and Translational Medicine, "Iuliu Hatieganu" University of Medicine and Pharmacy, Cluj-Napoca, Romania.

View Article

Download full-text PDF

Source
https://jeccr.biomedcentral.com/articles/10.1186/s13046-018-
Publisher Site
http://dx.doi.org/10.1186/s13046-018-0920-2DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6196003PMC
October 2018

Facing the Global Challenges of Access to Cancer Medication.

J Glob Oncol 2018 09;4:1-7

Abdul Raman Jazieh and Abdulaziz H. Al-Saggabi, National Guard Health Affairs, Riyadh, Saudi Arabia; Mark McClung, Amgen Oncology, Thousand Oaks, CA; Robert Carlson, National Comprehensive Cancer Network, Fort Washington, PA; Lowell E. Schnipper, Beth Israel Deaconess Medical Center; Barri Blauvelt, University of Massachusetts, Boston, MA; Alexandru Eniu, Cancer Institute "Ion Chiricuta", Cluj-Napoca, Romania; Yousuf Zafar, Duke Cancer Institute, Durham, NC; and David Kerr, Oxford University, Oxford, United Kingdom.

View Article

Download full-text PDF

Source
http://ascopubs.org/doi/10.1200/JGO.17.00205
Publisher Site
http://dx.doi.org/10.1200/JGO.17.00205DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6223443PMC
September 2018

PARP Inhibitors in Breast Cancer: Why, How, and When?

Breast Care (Basel) 2018 Jul 20;13(3):216-219. Epub 2018 Jun 20.

Breast Cancer Unit, American Hospital of Paris, Neuilly-sur-Seine, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1159/000490746DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6062717PMC
July 2018

Cancer Care and Control as a Human Right: Recognizing Global Oncology as an Academic Field.

Am Soc Clin Oncol Educ Book 2017 ;37:409-415

From the Cancer Institute Ion Chiricuta, Cluj-Napoca, Romania; Hematology-Oncology Division, University of Pennsylvania, Philadelphia, PA; National Cancer Institute, Bethesda, MD; Abramson Cancer Center, University of Pennsylvania, Philadelphia, PA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/EDBK_175251DOI Listing
December 2017

Extended Adjuvant Chemotherapy in Triple-Negative Breast Cancer.

Breast Care (Basel) 2017 Jul 27;12(3):152-158. Epub 2017 Jun 27.

Cancer Institute Ion Chiricuta, Cluj-Napoca, Romania.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1159/000478087DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5527164PMC
July 2017

Changing global policy to deliver safe, equitable, and affordable care for women's cancers.

Lancet 2017 02 1;389(10071):871-880. Epub 2016 Nov 1.

Institute of Cancer Policy, Kings Health Partners Comprehensive Cancer Centre, King's Centre for Global Health, King's Health Partners and King's College London, UK.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/S0140-6736(16)31393-9DOI Listing
February 2017

Low-Dose Oral Cyclophosphamide and Methotrexate Maintenance for Hormone Receptor-Negative Early Breast Cancer: International Breast Cancer Study Group Trial 22-00.

J Clin Oncol 2016 10 20;34(28):3400-8. Epub 2016 Jun 20.

Marco Colleoni, Giuseppe Viale, and Aron Goldhirsch, European Institute of Oncology; Giuseppe Viale, University of Milan, Milan; Lorenzo Gianni, Ospedale degli Infermi, Rimini; Fabio Puglisi, University Hospital of Udine, University of Udine, Udine; Carlo Tondini, Osp. Papa Giovanni XXIII, Bergamo; Katia Cagossi, Ospedale di Carpi, Carpi, Italy; Kathryn P. Gray, Shari Gelber, Richard D. Gelber, Meredith M. Regan, and Karen N. Price, International Breast Cancer Study Group Statistical Center; Kathryn P. Gray, Shari Gelber, Richard D. Gelber, and Meredith M. Regan, Dana-Farber Cancer Institute; Kathryn P. Gray and Richard D. Gelber, Harvard T.H. Chan School of Public Health; Richard D. Gelber and Meredith M. Regan, Harvard Medical School; Richard D. Gelber and Karen N. Price, Frontier Science and Technology Foundation, Boston, MA; István Láng, National Institute of Oncology, Budapest, Hungary; Beat Thürlimann, Kantonsspital, St Gallen; Beat Thürlimann, Elena Kralidis, and Daniel Rauch, Swiss Group for Clinical Cancer Research, Bern; Elena Kralidis, Kantonsspital Aarau, Aarau; Daniel Rauch, Spital Thun, Thun, Switzerland; Ehtesham A. Abdi, The Tweed Head Hospital, Tweed Heads, New South Wales and Griffith University, Southport, Queensland; Ehtesham A. Abdi and Jacquie Chirgwin, Australia and New Zealand Breast Cancer Trials Group; Jacquie Chirgwin, Box Hill and Maroondah Hospitals and Monash University, Melbourne, Victoria; Alan S. Coates, International Breast Cancer Study Group and University of Sydney School of Public Health, Sydney, New South Wales, Australia; Henry L. Gomez, Instituto Nacional de Enfermedades Neoplásicas, Lima, Peru; Barbro K. Linderholm, Institute of Clinical Sciences, Sahlgrenska Academy, University of Gothenburg, and Sahlgrenska University Hospital, Gothenburg, Sweden; and Alexandru Eniu, Cancer Institute Ion Chiricuta, Cluj, Romania.

View Article

Download full-text PDF

Source
http://ascopubs.org/doi/10.1200/JCO.2015.65.6595
Publisher Site
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5035120PMC
http://dx.doi.org/10.1200/JCO.2015.65.6595DOI Listing
October 2016

ESMO / ASCO Recommendations for a Global Curriculum in Medical Oncology Edition 2016.

Authors:
Christian Dittrich Michael Kosty Svetlana Jezdic Doug Pyle Rossana Berardi Jonas Bergh Nagi El-Saghir Jean-Pierre Lotz Pia Österlund Nicholas Pavlidis Gunta Purkalne Ahmad Awada Susana Banerjee Smita Bhatia Jan Bogaerts Jan Buckner Fatima Cardoso Paolo Casali Edward Chu Julia Lee Close Bertrand Coiffier Roisin Connolly Sarah Coupland Luigi De Petris Maria De Santis Elisabeth G E de Vries Don S Dizon Jennifer Duff Linda R Duska Alexandru Eniu Marc Ernstoff Enriqueta Felip Martin F Fey Jill Gilbert Nicolas Girard Andor W J M Glaudemans Priya K Gopalan Axel Grothey Stephen M Hahn Diana Hanna Christian Herold Jørn Herrstedt Krisztian Homicsko Dennie V Jones Lorenz Jost Ulrich Keilholz Saad Khan Alexander Kiss Claus-Henning Köhne Rainer Kunstfeld Heinz-Josef Lenz Stuart Lichtman Lisa Licitra Thomas Lion Saskia Litière Lifang Liu Patrick J Loehrer Merry Jennifer Markham Ben Markman Marius Mayerhoefer Johannes G Meran Olivier Michielin Elizabeth Charlotte Moser Giannis Mountzios Timothy Moynihan Torsten Nielsen Yuichiro Ohe Kjell Öberg Antonio Palumbo Fedro Alessandro Peccatori Michael Pfeilstöcker Chandrajit Raut Scot C Remick Mark Robson Piotr Rutkowski Roberto Salgado Lidia Schapira Eva Schernhammer Martin Schlumberger Hans-Joachim Schmoll Lowell Schnipper Cristiana Sessa Charles L Shapiro Julie Steele Cora N Sternberg Friedrich Stiefel Florian Strasser Roger Stupp Richard Sullivan Josep Tabernero Luzia Travado Marcel Verheij Emile Voest Everett Vokes Jamie Von Roenn Jeffrey S Weber Hans Wildiers Yosef Yarden

ESMO Open 2016 29;1(5):e000097. Epub 2016 Sep 29.

Department of General Medical Oncology , University Hospitals Leuven , Leuven , Belgium.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1136/esmoopen-2016-000097DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5070299PMC
September 2016

ESMO and WHO: 14 years of working in partnership on cancer control.

ESMO Open 2016 26;1(3):e000012. Epub 2016 May 26.

Department of Breast Tumors , Cancer Institute Ion Chiricuta Cluj-Napoca , Romania.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1136/esmoopen-2015-000012DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5070389PMC
May 2016

Differential peripheral blood gene expression profile based on Her2 expression on primary tumors of breast cancer patients.

PLoS One 2014 28;9(7):e102764. Epub 2014 Jul 28.

Department of Functional Genomics and Experimental Pathology, The Oncology Institute I. Chiricuta, Cluj-Napoca, Romania; Research Center for Functional Genomics, Biomedicine and Translational Medicine, Iuliu Hatieganu University of Medicine and Pharmacy, Cluj-Napoca, Romania; Department of Immunology, Iuliu Hatieganu University of Medicine and Pharmacy, Cluj Napoca, Romania.

View Article

Download full-text PDF

Source
http://journals.plos.org/plosone/article?id=10.1371/journal.pone.0102764PLOS
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4113305PMC
December 2015

PDGF beta targeting in cervical cancer cells suggest a fine-tuning of compensatory signalling pathways to sustain tumourigenic stimulation.

J Cell Mol Med 2015 Feb 14;19(2):371-82. Epub 2014 Oct 14.

Department of Functional Genomics and Experimental Pathology, The Oncology Institute "Prof. Dr. I. Chiricuta", Cluj-Napoca, Romania.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/jcmm.12449DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4407607PMC
February 2015

Morphologic and molecular subtype status of individual tumor foci in multiple breast carcinoma. A study of 155 cases with analysis of 463 tumor foci.

Hum Pathol 2014 Feb 18;45(2):409-16. Epub 2013 Oct 18.

Department of Pathology, University of Medicine and Pharmacy Targu Mures, 540139 Targu Mures, Romania.

View Article

Download full-text PDF

Source
https://linkinghub.elsevier.com/retrieve/pii/S00468177130042
Publisher Site
http://dx.doi.org/10.1016/j.humpath.2013.10.006DOI Listing
February 2014

Breast pathology guideline implementation in low- and middle-income countries.

Cancer 2008 Oct;113(8 Suppl):2297-304

Department of Pathology, College of Medicine, University of Florida, Jacksonville, Florida 32209, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/cncr.23833DOI Listing
October 2008

Locally advanced breast cancer: treatment guideline implementation with particular attention to low- and middle-income countries.

Cancer 2008 Oct;113(8 Suppl):2315-24

Division of Hematology-Oncology, Department of Internal Medicine, American University of Beirut Medical Center, Beirut, Lebanon. nagi.saghir@ aub.edu.lb

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/cncr.23836DOI Listing
October 2008

Effective but cost-prohibitive drugs in breast cancer treatment: a clinician's perspective.

Cancer 2008 Oct;113(8 Suppl):2353-8

Instituto Nacional de Cancer, Rio de Janeiro, Brazil.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/cncr.23837DOI Listing
October 2008

A Pilot Project to Develop Checklist-Based Recommendations on the Requirements for Clinical Cancer Research Centers in Countries with Limited Resources.

Authors:
Alexandru Eniu

Breast Care (Basel) 2008;3(1):33-35. Epub 2008 Feb 22.

Department of Breast Tumors, Cancer Institute 'I. Chiricuta', Cluj-Napoca, Romania.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1159/000114444DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2931016PMC
February 2008

Integrating biological agents into systemic therapy of breast cancer: trastuzumab, lapatinib, bevacizumab.

Authors:
Alexandru Eniu

J BUON 2007 Sep;12 Suppl 1:S119-26

Department of Breast Cancer, Cancer Institute Ion Chiricuta, Cluj-Napoca, Romania.

View Article

Download full-text PDF

Source
September 2007

Weekly administration of docetaxel and paclitaxel in metastatic or advanced breast cancer.

Oncologist 2005 Oct;10(9):665-85

Cancer Institute, Ion Chiricuta Cluj-Napoca, Romania.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1634/theoncologist.10-9-665DOI Listing
October 2005

Treatment of breast cancer in countries with limited resources.

Breast J 2003 May-Jun;9 Suppl 2:S67-74

Department of Medicine, Stanford University, Stanford, California 94305, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1046/j.1524-4741.9.s2.6.xDOI Listing
October 2003